Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, announced the successful acquisition of PKG Health, a leading innovator in movement disorder ...

The acquisition addresses urgent demand for objective Parkinson's measures in clinical trials, reinforcing Empatica's leadership with validated digital endpoints, and strengthening its presence in ...

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary ...

The KINECT-PRO™ analysis is the first and only of its kind to report both remission of tardive dyskinesia symptoms and associated improvements in patient-reported outcomes. Post-hoc analysis from ...

Some studies suggest vitamin E may help ease symptoms of tardive dyskinesia — but how strong is the evidence, and what does it really tell us? Note: The U.S. Food and Drug Administration (FDA) does ...

Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies geographically. Large trials are needed to assess safety and effectiveness. For ...

Subthalamic nucleus deep brain stimulation (STN-DBS) provides lasting benefits for patients with moderate-to-advanced Parkinson’s disease (PD), with sustained improvements in movement and quality of ...

Neurocrine (NBIX) announced new data from a post-hoc analysis of the Phase 4 KINECT-PRO open-label study confirming that robust rates of symptomatic remission of tardive dyskinesia were achieved with ...

SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of new data from the Phase 2 SAVITRI™ study, which showed statistically ...

Christoph U. Correll, MD, professor of psychiatry at The Zucker School of Medicine at Hofstra/Northwell and professor and chair of the department of child and adolescent psychiatry at Charité ...

Austedo and Austedo XR treat tardive dyskinesia and chorea related to Huntington’s disease in adults. The dosage varies depending on the condition. Austedo typically starts at 6 mg twice daily.